blog

How Total Blood Measurements and Binding Proteins Work Together to Estimate Free Hormone

Learn how total and free testosterone differ, why SHBG changes their relationship, and when free testosterone testing can add clinical context.

How Total Blood Measurements and Binding Proteins Work Together to Estimate Free Hormone
Share
PinterestFacebookLinkedInRedditTelegramX (Twitter)
Nov 7, 2026
Testosterone Basics

Total testosterone and free testosterone describe different parts of circulating hormone, and SHBG helps clinicians decide whether a total result needs more context when assessing possible testosterone deficiency.

This article is for informational purposes only and is not medical advice. A qualified clinician should interpret individual hormone results and make diagnosis or treatment decisions.

Total testosterone includes both bound and unbound hormone

Total testosterone measures testosterone across its circulating forms. It includes hormone attached to proteins as well as hormone that is not protein-bound. That makes it a measurement of the combined amount rather than a measurement of the unbound portion alone.

The European Association of Urology (EAU) guideline includes total testosterone in the biochemical assessment of male hypogonadism. This is the clinical condition in which symptoms or signs occur alongside biochemical evidence of testosterone deficiency.

Three components belong within the total measurement:

  • SHBG-bound testosterone: Hormone attached to sex hormone-binding globulin.
  • Albumin-bound testosterone: Hormone attached to another circulating protein called albumin.
  • Free testosterone: Hormone that is not bound to circulating proteins.

The word “total” is important because it describes what the test includes. It does not mean that the test separately identifies how much testosterone belongs to each component. A total result combines those forms into one measurement.

This explains why total testosterone remains useful without answering every question about hormone binding. Its clinical role is to contribute to the assessment of testosterone status. Our guide to the different information these measurements provide gives further context for reading them together.

Free testosterone focuses on the unbound portion

Free testosterone is the fraction that is not attached to circulating proteins. It is not a different hormone from total testosterone. It is one component already included within the total measurement.

The distinction is therefore about the form being assessed. Total testosterone combines protein-bound and unbound hormone. Free testosterone focuses on the unbound component rather than the combined amount.

A free-testosterone result may come from measurement or calculation. The EAU describes calculated free testosterone as an estimate derived from these inputs:

  • Total testosterone, which supplies the combined hormone measurement.
  • SHBG, which supplies information about a testosterone-binding protein.
  • Albumin, which accounts for another protein involved in binding.

A calculated result is not simply a second direct measurement of total testosterone. It uses the total result together with binding-protein information to estimate the unbound fraction. That difference explains why the laboratory method belongs in any discussion of the result.

Albumin also deserves attention even though SHBG often receives more emphasis. The EAU calculation approach includes both proteins. Describing calculated free testosterone as a calculation based only on total testosterone and SHBG leaves out one of the inputs identified in that guidance.

The practical comparison is straightforward: total testosterone describes the combined circulating amount, while free testosterone describes its unbound component. Neither term means that the other measurement is irrelevant.

SHBG changes the relationship between the two results

SHBG is a circulating protein that binds testosterone. The EAU notes that total testosterone values may change as circulating SHBG changes. As a result, the same total-testosterone value need not correspond to the same free-testosterone value when SHBG differs.

This is why a total result and a free result can tell different parts of the same story. Their relationship depends partly on binding proteins rather than on the total amount alone.

Higher SHBG can mean a lower free fraction

A higher-SHBG pattern can mean that more testosterone is protein-bound and that the free fraction is lower relative to total testosterone. A total result may therefore leave an important question about the unbound portion unresolved.

The EAU lists ageing and liver disease among factors associated with increased SHBG. Hyperthyroidism and HIV are also included. These associations give clinicians reasons to consider binding-protein context during an assessment.

The key comparison is between the combined hormone amount and its distribution across circulating forms. Higher SHBG does not make total testosterone meaningless. It changes how that measurement relates to the free fraction.

Lower SHBG can shift the relationship the other way

Lower SHBG can produce the opposite pattern in the relationship between total and free testosterone. A total result near the lower end of the range may therefore need additional interpretation rather than an assumption about the unbound component.

The EAU lists obesity, insulin resistance and type 2 diabetes among factors associated with decreased SHBG. These are associations rather than a diagnosis of why an individual has a particular SHBG result. Relevant health history and medication information belong in the clinician's assessment.

Our explanation of contrasting SHBG patterns expands on how binding context can help make sense of apparently mixed results.

Clinical assessment determines which measurements add value

Total and free testosterone are not competing treatments. The clinical question is whether the available measurements adequately describe testosterone status before any treatment decision is considered.

The EAU recommends measuring SHBG and calculating free testosterone in conditions characterized by altered SHBG. Free testosterone may also add context when total testosterone is borderline or near the lower limit and the total result alone does not settle the assessment.

According to the EAU, available cross-sectional and longitudinal data suggest that evaluating free testosterone can improve diagnostic accuracy in symptomatic men. The guideline highlights older men with obesity in particular. This supports targeted use of the additional measurement rather than treating it as a replacement for total testosterone.

Symptoms and test conditions belong in the assessment

The EAU describes diagnosis as requiring symptoms or signs together with biochemical evidence. Symptoms associated with hypogonadism are not exclusive to it. Neither symptoms alone nor an isolated free-testosterone number establishes the diagnosis.

The guideline recommends morning, fasting total-testosterone testing and confirmation of a pathological result before testosterone therapy. It reports that non-fasting testing can underestimate total testosterone by more than 30% in some circumstances. Test conditions therefore matter when interpreting an unexpectedly low measurement.

That finding is not a correction formula for adjusting an individual result. The supported approach is standardized testing and confirmation through the clinician's assessment. For more background on this issue, see why one low measurement needs follow-up.

Free-testosterone methods are not interchangeable

The EAU identifies equilibrium dialysis as the most accurate method for measuring free testosterone. Calculation using the inputs described above is an alternative. The guideline advises against direct free-testosterone measurement with available immunoassays because they cannot estimate it accurately.

This means that the label “free testosterone” does not fully describe how a result was obtained. A measured result and a calculated estimate should be identified as such. Knowing the method helps the clinician interpret what the laboratory has reported.

The EAU also discusses variation in laboratory practices and recommends reliable, standardized methods. Reference ranges and laboratory methods belong in the interpretation. A result should therefore be considered alongside its own laboratory information rather than detached from it.

A free-testosterone threshold has evidence limits

The EAU describes the evidence for a 220 pmol/L free-testosterone threshold in altered-SHBG settings as limited. The guidance reviewed here does not establish one universal free-testosterone threshold. That limitation belongs alongside the numerical result rather than being hidden behind a simple low-or-normal label.

The useful next step is to clarify how the result fits the clinical assessment. It is not to turn a single threshold into a personal treatment rule.

Focused questions can clarify the report

For a clinician discussion, the evidence supports questions such as:

  • Would SHBG measurement and calculated free testosterone add context to this total result?
  • Does the health history suggest that SHBG may be altered?
  • Was free testosterone measured or calculated, and which method was used?
  • Were the total-testosterone testing conditions appropriate, and does an abnormal result need confirmation?

These questions keep the discussion centered on what was tested and why it matters. They also separate the interpretation of a laboratory report from the later decision about whether treatment is appropriate.

Both measurements belong in the same clinical picture

Total testosterone describes the circulating whole, free testosterone describes its unbound part, and SHBG helps clinicians interpret both within the same clinical assessment.

How Testostra helps

Blood tests report hormone amounts rather than a ready-made explanation of protein binding, and Testostra works within that distinction through evidence-led education. Its biomarker coverage helps readers make sense of total and free testosterone alongside SHBG so they can bring clearer questions to a qualified clinician without mistaking an article for an individual assessment.

Read Resources

Sources

  1. Male Hypogonadism - EAU Guidelines on Sexual and Reproductive …

Continue reading

Distinguishing Functional Hormone Suppression from Gland Disease in Clinical Care
November 17, 2026
TRT & Emerging Research

Distinguishing Functional Hormone Suppression from Gland Disease in Clinical Care

Read Article
Why Clinicians Look Past Single Lab Results to Build a Complete Picture of Patient Health
November 17, 2026
Low Testosterone

Why Clinicians Look Past Single Lab Results to Build a Complete Picture of Patient Health

Read Article
Short-Term Hormone Surges During Exercise and the Evidence on Muscle Growth and Strength
November 17, 2026
Lifestyle & Natural Support

Short-Term Hormone Surges During Exercise and the Evidence on Muscle Growth and Strength

Read Article
Man walking outdoors after exercise in a green urban setting.
GET IN TOUCH

Have a testosterone question or research topic in mind?

Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.

Contact Testostra